# Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

> clinical trial · VERIFIED · 2026-08-04

Status: RECRUITING · Sponsor: Imunon · Condition: Ovarian Cancer

- Company: Imunon
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05739981

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.